content_image/207007.jpg
## Directors’ Report 

<img src='content_image/207007.jpg'>

The Directors of Benitec Biopharma Limited (‘the Company’ or ‘Benitec’) and its controlled entities (‘the Group’) present their report for the financial year ended 30 June 2014. 

## NON-EXECUTIVE DIRECTORS 

The following persons were Directors of Benitec Biopharma Limited during or since the end of the financial year. 

## Names, qualifications experience and special responsibilities 

Mr Peter Francis LLB, GRAD DIP (INTELLECTUAL PROPERTY) Non-Executive Chairman Appointed 23 February 2006 

Mr Peter Francis is a partner at Francis Abourizk Lightowlers (FAL), a firm of commercial and technology lawyers with offices in Melbourne, Australia. He is a legal specialist in the areas of intellectual property and licensing and provides legal advice to a large number of corporations and research bodies. 

Other Current Directorships of Listed Companies:  None 

Former Directorships of Listed Companies in last three years Xceed Capital Limited. 

Mr Kevin Buchi BA, MBA, CPA Non-Executive Director Appointed 14 April 2013 

Mr. Buchi served as Chief Executive Officer of Cephalon, Inc. through its $6.8 billion acquisition by Teva Pharmaceutical Industries in October 2011. After the acquisition Mr. Buchi served as Corporate Vice President, Global Branded Products of Teva Pharmaceuticals. Mr. Buchi joined Cephalon in 1991 and held various positions, including Chief Operating Officer, Chief Financial Officer and Head of Business Development prior to being appointed CEO. 

Mr. Buchi currently serves as President and CEO and a member of the Board of Directors of TetraLogic Pharmaceuticals. Mr Buchi is also on the Board of Directors of Stemline Therapeutics, Inc., Forward Pharma A/S, Alexza Pharmaceuticals, Inc. and Epirus Biopharmaceuticals. 

Mr Buchi originally trained as a synthetic organic chemist for the Eastman Kodak Company graduating from Cornell University with a Bachelor of Arts degree in chemistry. He holds Master’s degree in management from Kellogg Graduate School of Management at Northwestern University and is a Certified Public Accountant. 

Other Current Directorships of Listed Companies Stemline Therapeutics, Inc. and Alexza Pharmaceuticals, Inc. 

Former Directorships of Listed Companies in last three years Mesoblast Limited (Australia). 

